References:
1. Jobe, A.J., The new BPD: an arrest of lung development.Pediatr Res, 1999. 46 (6): p. 641-3.
2. Jobe, A.H. and M. Ikegami, Mechanisms initiating lung injury in
the preterm. Early Hum Dev, 1998. 53 (1): p. 81-94.
3. Jobe, A.H., Mechanisms of Lung Injury and Bronchopulmonary
Dysplasia. Am J Perinatol, 2016. 33 (11): p. 1076-8.
4. Schmidt, B., et al., Impact of bronchopulmonary dysplasia,
brain injury, and severe retinopathy on the outcome of extremely
low-birth-weight infants at 18 months: results from the trial of
indomethacin prophylaxis in preterms. JAMA, 2003. 289 (9): p.
1124-9.
5. Stoll, B.J., et al., Trends in Care Practices, Morbidity, and
Mortality of Extremely Preterm Neonates, 1993-2012. JAMA, 2015.314 (10): p. 1039-51.
6. Morley, C.J., et al., Nasal CPAP or intubation at birth for
very preterm infants. N Engl J Med, 2008. 358 (7): p. 700-8.
7. Network, S.S.G.o.t.E.K.S.N.N.R., et al., Early CPAP versus
surfactant in extremely preterm infants. N Engl J Med, 2010.362 (21): p. 1970-9.
8. Flannery, D.D., et al., Continuous Positive Airway Pressure
versus Mechanical Ventilation on the First Day of Life in Very
Low-Birth-Weight Infants. Am J Perinatol, 2016. 33 (10): p.
939-44.
9. Doyle, L.W., et al., Ventilation in Extremely Preterm Infants
and Respiratory Function at 8 Years. N Engl J Med, 2017.377 (4): p. 329-337.
10. Bancalari, E. and D. Jain, Bronchopulmonary Dysplasia: Can We
Agree on a Definition? Am J Perinatol, 2018. 35 (6): p.
537-540.
11. Shennan, A.T., et al., Abnormal pulmonary outcomes in
premature infants: prediction from oxygen requirement in the neonatal
period. Pediatrics, 1988. 82 (4): p. 527-32.
12. Jobe, A.H. and E. Bancalari, Bronchopulmonary dysplasia. Am J
Respir Crit Care Med, 2001. 163 (7): p. 1723-9.
13. Isayama, T., et al., Revisiting the Definition of
Bronchopulmonary Dysplasia: Effect of Changing Panoply of Respiratory
Support for Preterm Neonates. JAMA Pediatr, 2017. 171 (3): p.
271-279.
14. Jensen, E.A., et al., The Diagnosis of Bronchopulmonary
Dysplasia in Very Preterm Infants. An Evidence-based Approach. Am J
Respir Crit Care Med, 2019. 200 (6): p. 751-759.
15. Ballard, A.R., et al., Chorioamnionitis and subsequent
bronchopulmonary dysplasia in very-low-birth weight infants: a 25-year
cohort. J Perinatol, 2016. 36 (12): p. 1045-1048.
16. Jensen, E.A. and B. Schmidt, Epidemiology of bronchopulmonary
dysplasia. Birth Defects Res A Clin Mol Teratol, 2014. 100 (3):
p. 145-57.
17. Trembath, A. and M.M. Laughon, Predictors of bronchopulmonary
dysplasia. Clin Perinatol, 2012. 39 (3): p. 585-601.
18. Du, Z., et al., Relevance of clinical features in the
prognosis of bronchopulmonary dysplasia in premature infants. Exp Ther
Med, 2017. 14 (4): p. 3433-3440.
19. Doyle, L.W., et al., Low-dose dexamethasone facilitates
extubation among chronically ventilator-dependent infants: a
multicenter, international, randomized, controlled trial. Pediatrics,
2006. 117 (1): p. 75-83.
20. Vliegenthart, R.J.S., et al., Restricted Ventilation
Associated with Reduced Neurodevelopmental Impairment in Preterm
Infants. Neonatology, 2017. 112 (2): p. 172-179.
21. Gagliardi, L., et al., Do differences in delivery room
intubation explain different rates of bronchopulmonary dysplasia between
hospitals? Arch Dis Child Fetal Neonatal Ed, 2011. 96 (1): p.
F30-5.
22. Kim, F., et al., Revisiting the definition of bronchopulmonary
dysplasia in premature infants at a single center quaternary neonatal
intensive care unit. J Perinatol, 2021. 41 (4): p. 756-763.
23. Bhandari, V., The potential of non-invasive ventilation to
decrease BPD. Semin Perinatol, 2013. 37 (2): p. 108-14.
24. Watterberg, K.L., et al., Chorioamnionitis and early lung
inflammation in infants in whom bronchopulmonary dysplasia develops.Pediatrics, 1996. 97 (2): p. 210-5.
25. De Felice, C., et al., Histologic chorioamnionitis and
severity of illness in very low birth weight newborns. Pediatr Crit
Care Med, 2005. 6 (3): p. 298-302.
26. Hartling, L., Y. Liang, and T. Lacaze-Masmonteil,Chorioamnionitis as a risk factor for bronchopulmonary dysplasia:
a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal
Ed, 2012. 97 (1): p. F8-F17.
27. Lavoie, P.M., C. Pham, and K.L. Jang, Heritability of
bronchopulmonary dysplasia, defined according to the consensus statement
of the national institutes of health. Pediatrics, 2008.122 (3): p. 479-85.
28. Carrera, P., et al., Exome sequencing and pathway analysis for
identification of genetic variability relevant for bronchopulmonary
dysplasia (BPD) in preterm newborns: A pilot study. Clin Chim Acta,
2015. 451 (Pt A): p. 39-45.
29. Ambalavanan, N., et al., Integrated genomic analyses in
bronchopulmonary dysplasia. J Pediatr, 2015. 166 (3): p. 531-7
e13.
30. Bancalari, E. and T. del Moral, Bronchopulmonary dysplasia and
surfactant. Biol Neonate, 2001. 80 Suppl 1 : p. 7-13.
31. Li, J., et al., Exome Sequencing of Neonatal Blood Spots and
the Identification of Genes Implicated in Bronchopulmonary Dysplasia.Am J Respir Crit Care Med, 2015. 192 (5): p. 589-96.
32. Bhandari, V., et al., Familial and genetic susceptibility to
major neonatal morbidities in preterm twins. Pediatrics, 2006.117 (6): p. 1901-6.
33. Sandri, F., et al., The CURPAP study: an international
randomized controlled trial to evaluate the efficacy of combining
prophylactic surfactant and early nasal continuous positive airway
pressure in very preterm infants. Neonatology, 2008. 94 (1): p.
60-2.
34. Steinhorn, R., et al., Chronic Pulmonary Insufficiency of
Prematurity: Developing Optimal Endpoints for Drug Development. J
Pediatr, 2017. 191 : p. 15-21 e1.
35. Higgins, R.D., et al., Bronchopulmonary Dysplasia: Executive
Summary of a Workshop. J Pediatr, 2018. 197 : p. 300-308.